Academic Information
Research Interests
- Onco-Cardiology
- Chemobrain
- Pain Mechanism
- Sentrin/SUMO
- Medical Education
- Evidence-based Medicine
Areas of Expertise
- Pain Medicine
- Clinical Practice Guidelines
Related Links
Education & Training
Medical School
National Taiwan University, Harvard Chan School of Public Health
Internship
George Washington University Medical Center
Residency
Boston University Medical Center
Fellowship
Boston Children’s Hospital, Harvard Medical School
Board Certification
Anesthesiology
Medical School
National Taiwan University
School of Public Health
Harvard Chan School of Public Health
Publications
1. Yeh ET, Chang HM Oncocardiology-Past, Present, and Future: A Review, JAMA Cardiol. 2016 Dec 1;1(9):1066-1072
2. Chang HM, Yeh ET Potential of Oncocardiology-Reply, JAMA Cardiol. 2017 July 1;2(7):818
3. Yeh ET, Chang HM Cancer and Clot: Between a Rock and a Hard Place, J Am Coll Cardiol 2017 August 22; 70 (8): 939-941
4. Chang HM, Moudgil R, Scarabelli T, Okwuosa T, Yeh ET Cardiovascular Complications of Cancer Therapy: Best Practices in Diagnosis, Prevention, and Management: Part 1, J Am Coll Cardiol November 14;70(20):2536-2551, 2017
5. Chang HM, Okwuosa T, Scarabelli T, Moudgil R, Yeh ET Cardiovascular Complications of Cancer Therapy: Best Practices in Diagnosis, Prevention, and Management: Part 2, J Am Coll Cardiol November 14;70 (20):2552-2556, 2017
6. Chang HM NIH, Precision Medicine Initiative, All of Us Research Program, Use cases February 2018
What are the long-term cardiovascular effects of cancer therapy? Do childhood cancer survivors have reduced cardiac functions?
https://allofusresearchpriorities.ideascale.com/a/dtd/What-are-the-long-term-cardiovascular-effects-of-cancer-therapy-Do-childhood-cancer-survivors-have-reduced-cardiac-functions/197154-44880#idea-tab-comments
What are the genetic, comorbid risk factors, and anticancer agents that contribute to heart failure after cancer therapy
Cancer and clot: What is the incidence and timing of thromboembolism after cancer diagnosis
7. Yang FM, Zuo Y, Zhou W, Xia C, Hahm B, Sullivan M, Cheng J, Chang HM, Yeh ET sNASP Inhibits TLR Signaling to Regulate Immune Response in Sepsis. J of Clinical Investigation. In press. J Clin Invest. 2018 Jun 1;128(6):2459-2472. doi: 10.1172/JCI95720. Epub 2018 May 7.